LUIS JAVIER GARCIA FRADE-rekin lankidetzan egindako argitalpenak (21)

2020

  1. Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia

    European Journal of Haematology, Vol. 104, Núm. 3, pp. 259-270

2018

  1. Polymorphisms in receptors involved in opsonic and nonopsonic phagocytosis, and correlation with risk of infection in oncohematology patients

    Infection and Immunity, Vol. 86, Núm. 12

2017

  1. Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice

    International Journal of Hematology, Vol. 106, Núm. 4, pp. 508-516

2016

  1. Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice

    European Journal of Haematology, Vol. 97, Núm. 3, pp. 297-302

2015

  1. Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

    American Journal of Hematology, Vol. 90, Núm. 3, pp. E40-E43

2011

  1. Food anaphylaxis in antiphospholipid syndrome and thrombosis

    Allergologia et Immunopathologia, Vol. 39, Núm. 4, pp. 212-221

  2. The association of food anaphylaxis in antiphospholipid syndrome and thrombosis cannot be considered a coincidence

    Allergologia et Immunopathologia

2010

  1. Absence of accelerated atherosclerotic disease progression after intracoronary infusion of bone marrow derived mononuclear cells in patients with acute myocardial infarction-Angiographic and intravascular ultrasound-Results from the TErapia Celular Aplicada al Miocardio Pilot study

    American Heart Journal, Vol. 159, Núm. 6, pp. 1154.e1-1154.e8

2009

  1. Comparison of Neointimal Hyperplasia With Drug-Eluting Stents Versus Bare Metal Stents in Patients Undergoing Intracoronary Bone-Marrow Mononuclear Cell Transplantation Following Acute Myocardial Infarction

    American Journal of Cardiology, Vol. 103, Núm. 12, pp. 1651-1656

  2. Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion

    Leukemia Research

2008

  1. Impacto de la obstrucción microvascular persistente en el remodelado ventricular postinfarto tras el implante intracoronario de células mononucleadas de médula ósea: Un estudio de cardiorresonancia con contraste

    Revista Espanola de Cardiologia, Vol. 61, Núm. 6, pp. 602-610

  2. Nuevas perspectivas en el tratamiento y curación de las leucemias

    Anales de la Real Academia de Medicina y Cirugía de Valladolid, Núm. 45, pp. 275-288

  3. Tratamiento con anticoagulantes orales: dilemas y soluciones

    Anales de la Real Academia de Medicina y Cirugía de Valladolid, Núm. 45, pp. 71-84

2006

  1. Autologous mononuclear bone marrow transplantation for myocardial infarction: The Spanish experience

    Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair: From Basic Research to Clinical Applications (Springer US), pp. 187-201

  2. Oral anticoagulant treatment: Risk factors involved in 500 intracranial hemorrhages

    Journal of Thrombosis and Thrombolysis, Vol. 22, Núm. 2, pp. 113-120

2005

  1. Tratamiento del mieloma múltiple con trasplante autólogo de progenitores hematopoyéticos

    Anales de la Real Academia de Medicina y Cirugía de Valladolid, Núm. 43, pp. 93-109

2004

  1. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction

    Circulation Research, Vol. 95, Núm. 7, pp. 742-748

  2. Intracoronary stem cell transplantation in acute myocardial infarction

    Revista Espanola de Cardiologia, Vol. 57, Núm. 3, pp. 201-208

  3. Trombosis venosa en pacientes con factor V Leiden

    Anales de la Real Academia de Medicina y Cirugía de Valladolid, Núm. 42, pp. 49-59

2003

  1. Emphysematous gastritis and severe aplastic anemia

    Hematology Journal, Vol. 4, Núm. 1, pp. 82-84